Hereditary Skeletal and Skin Disorders Caused by Defects in the Biosynthesis of Chondroitin/Dermatan Sulfate, and Molecular Mechanisms of Pulmonary Metastasis.

[Hereditary Skeletal and Skin Disorders Caused by Defects in the Biosynthesis of Chondroitin/Dermatan Sulfate, and Molecular Mechanisms of Pulmonary Metastasis]. Yakugaku Zasshi. 2019;139(12):1495-1500 Authors: Mizumoto S Abstract The roles of chondroitin sulfate (CS) and dermatan sulfate (DS) have been demonstrated in various biological events such as the construction of the extracellular matrix, tissue development, and cell signaling through interactions with extracellular matrix components, morphogens, and growth factors. Human genetic diseases, including skeletal abnormalities, connective tissue diseases, and heart defects, were reported to be caused by mutations in the genes encoding glycosyltransferases, epimerases, and sulfotransferases that are responsible for the biosynthesis of CS and DS. Glycobiological approaches revealed that mutations in CS- and DS-biosynthetic enzymes led to reductions in their enzymatic activities and in the levels of CS and DS. Furthermore, CS at the surface of tumor cells plays a key role in pulmonary metastasis. A receptor for advanced glycation end-products (RAGE) was predominantly expressed in the lung, and was identified as a functional receptor for CS chains. CS and anti-RAGE antibodies inhibited the pulmonary metastasis of not only Lewis lung carcinoma but also B16 melanoma cells. Hence, RAGE and CS are potential targets of drug discovery for pulmonary metastasis and a number of other pathological conditions invol...
Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - Category: Drugs & Pharmacology Authors: Tags: Yakugaku Zasshi Source Type: research

Related Links:

SummaryThe management of head and neck tumors is challenging and requires a  multidisciplinary approach. Besides the common histology of squamous cell cancer, other histologies like adenoid cystic carcinoma, mucosal melanoma, and adenocarcinoma are often present. These tumors are radioresistant and need high radiation doses. Photon beam therapy is often limited by the norm al tissue tolerance, and particle therapy using protons or carbon ions is a valuable treatment option. Due to their dosimetric advantages, protons enable deposition of high tumor doses, while optimally sparing the surrounding tissue. Carbon ion...
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research
The discovery of immune checkpoint inhibitors (ICIs), which include anti-programmed cell death protein-1 (PD-1), its ligand (PD-L1) and anti-cytotoxic T cell lymphocyte-associated protein-4 (CTLA-4), has transformed the field of oncology, with indications continuing to increase. For example, anti-PD1 and anti-CTLA-4 ICIs, which include nivolumab, pembrolizumab and ipilimumab, are US Food and Drug Administration/European Medicines Agency approved for a variety of cancers, such as melanoma and non-small cell lung carcinoma (NSCLC) [1]. Considered the Achilles' heel of ICIs, however, are immune-related adverse events (irAEs) ...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Original Articles: Research letters Source Type: research
Discussion[99mTc]-tilmanocept SPECT/CT resulted in an excellent choice for preoperative lymphatic mapping and presented an optimal biodistribution with a rapid injection-site clearance and persistent SLN retention that could lead to improved accuracy of sentinel node identification in selected cases of melanoma, oral and breast cancer.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research
ConclusionsThe findings suggest that ccRCC and pRCC differ with respect to PD-L1 regulation by IFN- γ-signaling. HighPD-L1-mRNA levels in tumor tissues with a positive IFN- γ signature favorably affect OS and DFS.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
Conditions:   Non-melanoma Skin Cancer;   Basal Cell Carcinoma;   Squamous Cell Carcinoma Intervention:   Biological: Imvamune Sponsor:   Ivan Litvinov Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Measuring the structural and functional status of tumor microenvironment for malignant melanoma (MM) and basal cell carcinoma (BCC) is of profound significance in understanding dermatological condition for biopsy. However, conventional optical imaging techniques are limited to visualize superficial skin features and parameter information is deficient to depict pathophysiology correlations of skin diseases. Here, we demonstrate a preclinical device, all-optically integrated photoacoustic and optical coherence tomography (AOPA/OCT), that, for the first time, can simultaneously provide label-free biomarkers of vascular patter...
Source: IEE Transactions on Medical Imaging - Category: Biomedical Engineering Source Type: research
Conditions:   Colitis;   Lung Non-Small Cell Carcinoma;   Malignant Genitourinary System Neoplasm;   Malignant Solid Neoplasm;   Melanoma Interventions:   Biological: Infliximab;   Biological: Vedolizumab Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Abstract Immunotherapy shows remarkable efficacy in treating several types of cancer such as melanoma, leukemia, and lung carcinoma, but its therapeutic effect for most solid tumors is still limited. Various cancer therapies, such as chemotherapy, radiotherapy and phototherapy, kill solid tumors through non-inflammatory apoptosis or ablation, rather than making solid tumors immunogenic. As a highly-inflammatory programmed cell death (PCD), pyroptosis provides a great opportunity to alleviate immunosuppression and promote a systemic immune response in treating solid tumors. Herein, by fusing breast cancer membrane ...
Source: Biomaterials - Category: Materials Science Authors: Tags: Biomaterials Source Type: research
ConclusionsWe found that the occurrence of DM from the primary site as well as rate of incidence was dependent on histopathological factors.
Source: Oral Radiology - Category: Radiology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cardiology | Dermatology | Drugs & Pharmacology | Genetics | Heart | Japan Health | Melanoma | Molecular Biology | Science | Skin | Skin Cancer | Study